Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Drew Lines & Caesar Reddington Make History as They Are Among the First Group of Hip Hop Artists to Perform at Brat Fest
    Drew Lines & Caesar Reddington Make History as They Are Among the First Group of Hip Hop Artists to Perform at Brat Fest World News
  • Verijet Receives Agents for Change Green Travel Award at Sustainable Development Goals Gala for United Nations Assembly Week Business
  • LTV Day 1007: Putin’s Nuclear Threats: Limits of Impotence – Latynina.tv – Alexey Arestovych World News
  • Global Nicotine Gum Market Is Projected To Grow At A 5.37% Rate Through The Forecast Period World News
  • Dr. Zamip Patel publishes new Blog with easy-to-understand articles about male urology and infertility issues World News
  • DHS Releases FY23 Targeted Violence and Terrorism Prevention Notice of Funding World News
  • Breast Cancer Liquid Biopsy Market Is Projected To Reach $357.05 Million by 2027 Business
  • War Day 222: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 222: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News

IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Posted on February 14, 2025 By NewsEditor

If you suffered losses in Novo Nordisk S/A, Contact KT Law

KlaymanToskes Investigates on Behalf of Investors Who Were Recommended Novo Nordisk A/S Investments By Their Broker/Advisor

Novo Nordisk S/A (NYSE:NVO)

NEW YORK, NY, UNITED STATES, February 4, 2025 /EINPresswire.com/ — National investment loss and securities lawyers KlaymanToskes issues an important notice to investors who suffered significant losses in Novo Nordisk S/A (NYSE: NVO). The law firm urges customers of brokerage firms and financial advisors who suffered investment losses in excess of $100,000 in Novo Nordisk S/A to contact the firm immediately at 888-997-9956. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

KlaymanToskes is investigating brokerage firms and financial advisors that recommended investments in Novo Nordisk to their customers. On December 20, 2024, Novo Nordisk disclosed that only 57.3% of patients in its REDEFINE-1 trial were able to remain on the highest CagriSema dose, compared to 82.5% for cagrilintide and 70.2% for semaglutide. Following this news, Novo Nordisk’s stock plunged nearly 18%.

Our investigation has led the law firm to believe that investment firms and their financial advisors may have failed to act in the best interest of their customers, and misrepresented the risk-factors related to investments in Novo Nordisk S/A, in addition to failing to conduct due diligence on Novo Nordisk’s investment offering, leading to unsuitable recommendations.

Financial advisors and their firms may be held liable for any losses incurred by their customers in the event of failure to act in the best interest of the customer, unsuitable investment recommendations, misrepresentations or omissions of material facts, and/or an overconcentration of the customer’s portfolio in one particular investment, class, or market sector. Further, financial professionals and their firms cannot disregard a customer’s risk-tolerance when making investment recommendations.

Depending on your circumstances, you may be entitled to recover your losses through FINRA arbitration, which may result in a greater and additional recovery to solely participating and waiting for any recovery in any class action lawsuit.

Investors who suffered losses over $100,000 in Novo Nordisk S/A are encouraged to contact attorney Steven D. Toskes at (888) 997-9956 or by email at [email protected] in furtherance of our investigation. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

About KlaymanToskes

KlaymanToskes is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation on behalf of retail and institutional investors throughout the world in large and complex securities matters. The firm has recovered over $250 million in FINRA arbitrations and over $350 million in other securities litigation matters. KlaymanToskes has office locations in California, Florida, New York, and Puerto Rico.

Contact

Steven D. Toskes, Esq.
KlaymanToskes, P.A.
+1 888-997-9956
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

February 04, 2025, 15:57 GMT


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Business

Post navigation

Previous Post: Analyzing Growth Drivers, Market Share, Segments, Trends
Next Post: Saudia’s Chief Guest Experience Officer, Mr. Rossen Dimitrov, to Deliver Keynote at Airport Expansion Conference 2025

Related Posts

  • Amphibious Vehicle Global Market 2024 To Reach $6.11 Billion By 2028 At Rate Of 10.1% Business
  • Lookah Launches New Dragon Egg Portable E-Rig Business
  • Koa Health expands anxiety digital tools for children and adolescents to the U.S. Business
  • JP Painting Sydney Sets the Standard for Residential, Commercial Painting Across Sydney Business
  • Sound Reinforcement Market Size, Share, Trends And Global Outlook For 2023-2032 Business
  • Shaping the Future of Digital Money Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Ataxia Market Analysis Report Exploring Demand Patterns and Competitive LandscapeNovember 20, 2026
  • SEOPS Expands Waymaker Rideshare Program with Third Falcon 9 Launch with SpaceXNovember 20, 2026
  • The Assistive Technologies Market for Visually Impaired Expected to Reach $12.71 Billion by 2030November 19, 2026
  • Sabio Group hires Simon Foot to lead Sabio Consulting as AI-first Transformation AcceleratesNovember 19, 2026
  • Atenolol Market Outlook Report Including Segment Analysis and Strategic Industry InsightsNovember 18, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Stirling CBD Reports on Popularity of CBD Supplements in Chiropractic Offices Business
  • 5th Anti-War Conference in Tallinn, Estonia. Panel: Four Fronts, Directions and Scenarios. 2023 Oct. World News
  • Carmel Valley’s First Cannabis Dispensary Opens for Business World News
  • Stirling CBD Forecasts CBD Use to Grow in 2023 Business
  • The Burgeoning Transportation Industry Is Set To Drive The High Performance Adhesives Market In The Forecast Period Business
  • Medical Adhesive Tapes Market Size, Share And Growth Analysis For 2024-2033 World News
  • Adega Gaucha’s Three Florida Restaurants Earn OpenTable Diners’ Choice Awards in 2026 Business
  • Day 183 – Latynina.tv – Alexey Arestovych World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .